UROVANT SCIENCES LTD's ticker is UROV and the CUSIP is G9381B108. A total of 41 filers reported holding UROVANT SCIENCES LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $5,507,000 | +348.5% | 341,426 | +159.7% | 0.00% | – |
| Q3 2020 | $1,228,000 | -5.1% | 131,487 | 0.0% | 0.00% | – |
| Q2 2020 | $1,294,000 | +6.8% | 131,487 | 0.0% | 0.00% | – |
| Q1 2020 | $1,212,000 | -40.6% | 131,487 | 0.0% | 0.00% | – |
| Q4 2019 | $2,039,000 | +63.8% | 131,487 | 0.0% | 0.00% | – |
| Q3 2019 | $1,245,000 | +19.7% | 131,487 | 0.0% | 0.00% | – |
| Q2 2019 | $1,040,000 | -15.5% | 131,487 | +7.3% | 0.00% | – |
| Q1 2019 | $1,231,000 | +102.5% | 122,487 | +32.7% | 0.00% | – |
| Q4 2018 | $608,000 | – | 92,324 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|